Shattuck Labs Total Current Liabilities 2011-2026 | STTK

Annual Total Current Liabilities Shattuck Labs

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
7.05 M	8.92 M	11.5 M	25 M	24.6 M	16.8 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
25 M	7.05 M	15.6 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
Benitec Biopharma BNTC	1.8 M	$ 10.98	-4.52 %	$ 452 M	USA
Milestone Pharmaceuticals MIST	14 M	$ 1.36	-20.0 %	$ 45.5 M	Canada
I-Mab IMAB	576 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
PainReform Ltd. PRFX	2.44 M	$ 2.28	-0.44 %	$ 1.03 M	Israel
ARCA biopharma ABIO	13 M	-	1052.0 %	$ 415 M	USA
AgeX Therapeutics AGE	5.91 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	45.3 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	5.75 M	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	1.93 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
Assembly Biosciences ASMB	48.8 M	$ 28.46	3.45 %	$ 319 M	USA
Avenue Therapeutics ATXI	816 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	60.7 M	$ 1.37	-4.2 %	$ 350 M	Britain
Adverum Biotechnologies ADVM	22.9 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	19 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	25 M	-	-9.65 %	$ 45.9 M	USA
Axsome Therapeutics AXSM	379 M	$ 156.92	-1.23 %	$ 7.81 B	USA
Ayala Pharmaceuticals AYLA	7.54 M	-	-	$ 7.46 M	Israel
AbCellera Biologics ABCL	64.3 M	$ 3.4	-3.68 %	$ 1.02 B	Canada
Atreca BCEL	16.3 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	82.4 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	1.83 B	-	0.49 %	$ 251 B	Cayman-islands
BioMarin Pharmaceutical BMRN	759 M	$ 54.13	-1.64 %	$ 10.4 B	USA
Calithera Biosciences CALA	14 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	25.6 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	63 M	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	5.4 M	-	-74.18 %	$ 955 K	USA
Compugen Ltd. CGEN	22.6 M	$ 2.09	-0.95 %	$ 195 M	Israel
Coherus BioSciences CHRS	140 M	$ 1.52	-5.59 %	$ 178 M	USA
Checkpoint Therapeutics CKPT	20.1 M	-	-	$ 169 M	USA
Clovis Oncology CLVS	125 M	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
Corbus Pharmaceuticals Holdings CRBP	20.7 M	$ 8.6	-3.8 %	$ 115 M	USA
Curis CRIS	19 M	$ 0.77	1.89 %	$ 4.86 M	USA
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA